Cryomass Financial Statements From 2010 to 2024
| CRYM Stock | USD 0.02 0.0003 1.89% |
Check Cryomass Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cryomass Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cryomass financial statements analysis is a perfect complement when working with Cryomass Technologies Valuation or Volatility modules.
Cryomass |
Cryomass Technologies OTC Stock Shares Outstanding Analysis
Cryomass Technologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cryomass Technologies Shares Outstanding | 202.53 M |
Most of Cryomass Technologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cryomass Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cryomass Technologies has 202.53 M of shares currently outstending. This is 12.18% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 64.58% higher than that of the company.
Cryomass Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cryomass Technologies's current stock value. Our valuation model uses many indicators to compare Cryomass Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cryomass Technologies competition to find correlations between indicators driving Cryomass Technologies's intrinsic value. More Info.Cryomass Technologies is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cryomass Technologies' earnings, one of the primary drivers of an investment's value.About Cryomass Technologies Financial Statements
Cryomass Technologies investors utilize fundamental indicators, such as revenue or net income, to predict how Cryomass OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. Cryomass Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.